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A hamartoma is defined as a benign tumor or nodular 
growth that is composed of proliferating mature 
histologically normal cells that normally reside at the 
affected tissue. In ophthalmic jargon, iris hamartomas 
traditionally refer to Lisch nodules which are 
encountered in patients with neurofibro-matosis type 1 
(NF1). 
Classification 
Apart from the Lisch nodules, iris mamillations, iris 
nevi and melanocytomas must also be considered as 
hamartomatous benign lesions. 




Lisch nodules are dome-shaped gelatinous masses 
developing on the surface of the iris. Gold-tan to br wn 
in color, they may grow up to 2 mm in diameter and 
attain variable sizes on the same iris. The presence of 
Lisch nodules is the most common clinical sign of NF1. 
Phenotype / cell stem origin 
Lisch nodules are postulated to arise from mast cells, 
pigmented cells and fibroblast-like cells. 
Epidemiology 
Lisch nodules are more frequent in post-pubertal NF1 
patients evidenced by the finding that only 19% of 
patients with NF1 below the age of 5 years  
 
display Lisch nodules whereas this rate rises to 92% in 
adult NF1 patients. Ninety-three percent of cases ar  
bilaterally affected and an average of 25 nodules can be 
counted on each iris. Once developed, they remain 
stable throughout life. 
Clinics 
In 80% of eyes, Lisch nodules may be found in the 
inferior quadrants of the iris and this may be related to 
greater sun exposure, one of the postulated factors in 
the development of these benign tumefa-ctions. Lisch 
nodules are almost always patho-gnomonic for NF1. 
However, they may occasion-ally be seen in some othr 
rare conditions including Watson syndrome and 
neurofibromatosis type 2. The differential diagnosis of 
Lisch nodules must include iris mamillations, irido-
corneo-endothelial syndrome, Rieger's anomaly or 
syndrome, iris nevi, melanoma and inflammatory 
conditions like sarcoidosis, lepra, tuberculosis and 
syphilis. Differentiating Lisch nodules from iris 
mamilla-tions may sometimes be particularly 
important. Iris mamillations are usually unilateral, 
causing hetero-chromia iridis and are often associated 
with ocular melanocytosis. In contrast to Lisch nodules, 
iris mamillations show the same color as the underlying 
iris, are regularly spaced over the iris and increase in 
size as they get closer to the pupillary margin. These 
eyes should be closely surveyed because of the risk of 
pigmentary glaucoma which results from excessive 
pigment accumulation occluding the iridocorneal angle. 
Pathology 
Histopathologically, Lisch nodules are composed of 
melanocytes and spindle cells, usually concentrated on 
the superficial layers of the iris stroma. 
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Typical light brown-tan colored Lisch nodules on the iris of a 
patient with neurofibromatosis type 1. 
The spindle cells are larger than the normal iris 
melanocytes. Immunohistochemical studies show 
positive reaction against vimentin, smooth muscle atin 
and neuron specific enolase. 
 
Multiple, regularly spaced protuberances or "mamillations" on 
the surface of the iris. 
Treatment 
Currently there is neither treatment for Lisch nodules 
nor any necessity to treat these small benign lesions 
which do not interfere with visual function. 
Prognosis 
The prognosis is excellent for eyes that contain iris 
Lisch nodules, unless associated with other ocular 





This is the most frequent melanocytic lesion involving 
the iris and mostly localized within the stroma. 
Epidemiology 
Iris nevi can be seen in 4-6% of the population, 
probably more frequently in light irides. Rare in 
children, iris nevi become more apparent in puberty 
and adolescence. 
Clinics 
Iris nevi can be found on any part of the iris, measuring 
less than 3 mm in diameter and less than 1 mm in 
thickness. Most nevi are pigmented but sometimes thy
may be amelanotic and associated with clear cysts. 
There is no prominent intralesional vascularity. On rare 
occasions an iris nevus may present as small multiple 
overlapping nodules called as the "tapioca" type. There 
may be an associated sector cataract. Iridocorneal angle 
involvement, deformation of the pupillary margin and 
development of ectopium uvea and minimal growth 
over time can be observed with iris nevi and do not 
necessarily imply malignant transformation. Most nevi 
do not interfere with pupillary dilation or constriction. 
The diagnosis is often made on clinical grounds. 
Ancillary tests include iris fluorescein angiography, 
ultrasound biomicroscopy (UBM), transillumination 
and anterior segment optical coherence tomography. 
UBM may measure the thickness of the lesion, show 
the cystic components and more importantly 
demonstrate involvement of the ciliary body. 
Fluorescein angiography is often non-contributory due 
to heavy pigmentation of nevi but occasionally may 
reveal diffuse, tortuous and anastomotic vascularization 
within the tumor. These tests are seldom reliable 
however in the differential diagnosis and in 
differentiating benign lesions from the malignant. 
 
Sector iris nevus on a light colored iris. 
Pathology 
Histopathologically iris nevi are traditionally grouped 
into 4 subtypes. 
Epitheloid cell nevus is composed of intrastromal nests 
of small, polyhedral cells with basophilic nuclei located 
near the nuclear membrane. 
Intrastromal cell nevus is formed by lightly pigment d 
ovoid or spindle shaped cells with dot-like nuclei. 
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Spindle cell nevus has a hypocellular stromal 
component and a cohesive plaque on the anterior 
surface of the lesion. 
Borderline spindle cell nevus has almost identical 
features with the former but some cells may have small 
nuclei. This last subtype may sometimes be interpreted 
as melanoma. Mitotic activity is absent in all these 
types of iris nevi. 
Treatment 
Observation is the preferred management for iris nevi. 
Approximately 5% of iris nevi show unequivocal 
evidence of growth in 5 years. Basal diameter larger 
than 3 mm, documented rapid growth, extraocular 
extension or invasion of the ciliary body, prominent 
vascularity, and pigment dispersion and development 
of high intraocular pressure are all indicators of a 
suspicious iris melanoma and prompt therapeutic acton 
should be taken. 
Prognosis 
Systemic and ocular prognoses are excellent in patients 




Alias: Magnocellular nevus 
This is a rare type of darkly pigmented melanocytic 
lesion, generally found on the optic disc, but also 
described in the choroid, conjunctiva and sclera. 
Epidemiology 
Usually diagnosed in adults, melanocytomas usually 
develop in pigmented persons with a female sex 
predilection. 
Clinics 
Iris melanocytoma is a solitary deeply pigmented 
nodular tumor with irregular borders and surface. The 
majority of the lesions develop in the inferior and 
lateral parts of the iris and the iris root is particularly 
involved. In fact, it is believed that 85% of ciliary body 
melanocytomas erupt into the anterior chamber via the 
peripheral iris. Melano-cytoma may undergo 
spontaneous necrosis and macrophages containing 
large amounts of pigment may obstruct the trabecular 
meshwork and cause melanocytomalytic glaucoma. 
This type of glau-coma is often refractory to medical 
treatment. Other findings include pigment seedings on 
the iris stroma, iridocorneal angle, anterior chamber 
and corneal endothelium. The diagnosis of iris melano-
cytoma is not always straightforward. Most cases are 
initially classified as iris nevi. Those tumors that grow 
or extend outside the eye eventually undergo a 
diagnostic incisional or an excisional biopsy and it is 
only after the histopathological examination that the 
diagnosis of melanocytoma is made with certainty. In 
selected patients, fine needle aspiration biopsy mabe 
helpful in differenttiating from melanoma. 
 
Dark brown iris lesion that proved to be a melanocytoma 
following iridectomy. 
Pathology 
A melanocytoma is composed of regular, large 
polyhedral cells with abundant cytoplasms full of 
pigment. Mitotic figures are usually absent or distinctly 
few. The nuclear-cytoplasmic ratio is low. Smaller 
deeply pigmented fusiform cells may also be 
occasionally encountered. Massive pigmentation 
almost always impedes the observation of cellular 
details under light microscopy. This problem is 
circumvented by appropriate bleaching techniques. 
 
A: Typically, melanocytoma cells are packed with large 
amounts of melanin pigment which limits the study of further 
histopathological details. (HE, X 80). 
B: After bleaching, the benign character of the plump cells with 
small, bland nuclei within large cytoplasms can be better 
appreciated. 
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Treatment 
By virtue of their benign nature, iris melano- 
cytomas are best managed by regular observation. The 
presence of high intraocular pressure, continuous 
growth or a strong suspicion for a melanoma mandate 
surgical excisional biopsy whenever possible. Even 
after complete removal of the tumor, high intraocular 
pressure may persist only to subside months later. 
Enucleation is rarely performed for a melanocytoma. 
Prognosis 
Melanocytomas have long been considered as benign 
and stable lesions. However long-term observations 
now show that there may be a documented growth in 
23% of the tumors by 5 years and in 48% of tumors at 
the end of 10 years. These tumors may even develop 
extrascleral extensions in which case, differentiati g 
the tumor from a melanoma may become very difficult. 
On rare occasions, iris melanocytoma may transform 
into a melanoma. For these reasons close observa-tion 
is mandatory in patients with iris or iridociliary 
melanocytomas. 
Genes involved and proteins 
Note 
Lisch nodules are almost always associated with 
neurofibromatosis type 1 whose gene was cloned on 
chromosome 17q11.2. There are 3 embedded genes 
knowns as EVI2A, EVI2B and oligodend-rocyte 
myelin glycoprotein. The cytoplasmic protein product 
is called neurofibromin which controls mammalian 
target of rapamycin (MTOR). This serine/threonine 
kinase has a regulatory function on cellular growth and 
proliferation. Neurofibromin has also a tumor supressor 
function by inactivating a cellular proto-oncogene, p21 
ras. 
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